Literature DB >> 11597184

Graph models of oncogenesis with an application to melanoma.

M D Radmacher1, R Simon, R Desper, R Taetle, A A Schäffer, M A Nelson.   

Abstract

We describe several analytical techniques for use in developing genetic models of oncogenesis including: methods for the selection of important genetic events, construction of graph models (including distance-based trees, branching trees, contingency trees and directed acyclic graph models) from these events and methods for interpretation of the resulting models. The models can be used to make predictions about: which genetic events tend to occur early, which events tend to occur together and the likely order of events. Unlike simple path models of oncogenesis, our models allow dependencies to exist between specific genetic changes and allow for multiple, divergent paths in tumor progression. A variety of genetic events can be used with the graph models including chromosome breaks, losses or gains of large DNA regions, small mutations and changes in methylation. As an application of the techniques, we use a recently published cytogenetic analysis of 206 melanoma cases [Nelson et al. (2000), Cancer Genet. Cytogenet.122, 101-109] to derive graph models for chromosome breaks in melanoma. Among our predictions are: (1) breaks in 6q1 and 1q1 are early events, with 6q1 preferentially occurring first and increasing the probability of a break in 1q1 and (2) breaks in the two sets [1p1, 1p2, 9q1] and [1q1, 7p2, 9p2] tend to occur together. This study illustrates that the application of graph models to genetic data from tumor sets provide new information on the interrelationships among genetic changes during tumor progression. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11597184     DOI: 10.1006/jtbi.2001.2395

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  11 in total

1.  Modeling cancer progression via pathway dependencies.

Authors:  Elena J Edelman; Justin Guinney; Jen-Tsan Chi; Phillip G Febbo; Sayan Mukherjee
Journal:  PLoS Comput Biol       Date:  2008-02       Impact factor: 4.475

2.  Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors.

Authors:  Carol Sweeney; Kenneth M Boucher; Wade S Samowitz; Roger K Wolff; Hans Albertsen; Karen Curtin; Bette J Caan; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2009-01       Impact factor: 5.006

3.  The temporal order of genetic and pathway alterations in tumorigenesis.

Authors:  Moritz Gerstung; Nicholas Eriksson; Jimmy Lin; Bert Vogelstein; Niko Beerenwinkel
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

4.  Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy.

Authors:  Michal Ozery-Flato; Chaim Linhart; Luba Trakhtenbrot; Shai Izraeli; Ron Shamir
Journal:  Genome Biol       Date:  2011-06-29       Impact factor: 13.583

5.  Inferring tree causal models of cancer progression with probability raising.

Authors:  Loes Olde Loohuis; Loes Olde Loohuis; Giulio Caravagna; Alex Graudenzi; Daniele Ramazzotti; Giancarlo Mauri; Marco Antoniotti; Bud Mishra
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

6.  Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling.

Authors:  Ramon Diaz-Uriarte
Journal:  BMC Bioinformatics       Date:  2015-02-12       Impact factor: 3.169

Review 7.  Cancer evolution: mathematical models and computational inference.

Authors:  Niko Beerenwinkel; Roland F Schwarz; Moritz Gerstung; Florian Markowetz
Journal:  Syst Biol       Date:  2014-10-07       Impact factor: 15.683

8.  TrAp: a tree approach for fingerprinting subclonal tumor composition.

Authors:  Francesco Strino; Fabio Parisi; Mariann Micsinai; Yuval Kluger
Journal:  Nucleic Acids Res       Date:  2013-07-27       Impact factor: 16.971

9.  Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model.

Authors:  Paola Lecca; Nicola Casiraghi; Francesca Demichelis
Journal:  Front Genet       Date:  2015-10-13       Impact factor: 4.599

Review 10.  Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence.

Authors:  Hayley P Ellis; Mark Greenslade; Ben Powell; Inmaculada Spiteri; Andrea Sottoriva; Kathreena M Kurian
Journal:  Front Oncol       Date:  2015-11-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.